Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Stanford University
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01631318
First received: June 26, 2012
Last updated: May 18, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2019 (Final data collection date for primary outcome measure)